Trials / Completed
CompletedNCT01509209
Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis
Efficacy and Safety of Cossac L Tablet in Vasomotor Rhinitis Patients : A Randomized, Double-blind, Placebo-controlled, Phase 3 Clinical Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis
Detailed description
randomized, double-blind, placebo-controlled, phase 3
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pseudoephedrine / Levocetirizine | tablet, BID everyday |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-01-12
- Last updated
- 2013-05-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01509209. Inclusion in this directory is not an endorsement.